Secondaries Announced 12.14.17

IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis.

If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today!

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.

Company: Global Blood Therapeutics
Symbol: GBT
Price: Last Trade $39.40
Trade Date: 12/15
Shares: 2.6 million ($100m cash raise)
Re-Offer Range: Subscription Needed
Underwriter(s): Cantor Fitzgerald
Description: Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Rating = Subscription Needed

Company: The Chefs’ Warehouse, Inc.
Symbol: CHEF
Price: Last Trade $20.00
Trade Date: 12/15
Shares: 1.9 million
Re-Offer Range:Subscription Needed
Underwriter(s): Jefferies
Description:The Chefs’ Warehouse, Inc. is a premier distributor of specialty food products in the United States and Canada focused on serving the specific needs of chefs who own and/or operate some of the nation’s leading menu-driven independent restaurants, fine dining establishments, country clubs, hotels, caterers, culinary schools, bakeries, patisseries, chocolatiers, cruise lines, casinos and specialty food stores.
Rating = Subscription Needed

Company: Univar, Inc.-BLOCK
Symbol: UNVR
Price: Last Trade $28.79
Trade Date: 12/15
Shares: 10 million
Re-Offer Range: Subscription Needed
Underwriter(s): Goldman Sachs & Co.
Description: Founded in 1924, Univar is a global chemical and ingredients distributor and provider of value-added services, working with leading suppliers worldwide.
Rating = Subscription Needed

Company: Verastem, Inc. – Block
Symbol: VSTM
Price: Last Trade $3.65
Trade Date: 12/15
Shares: 8.4 million
Re-Offer Range: Subscription Needed
Underwriter(s): BTIG
Description: Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways.
Rating = Subscription Needed